EA
BMRA icon

Emerald Advisers’s Biomerica BMRA Stock Holding History

Emerald Advisers’s Portfolio BMRA Stock Details BMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,375
Closed -$63.6K – 221
2022
Q4 		$63.6K Hold
2,375
– – ﹤0.01% 212
2022
Q3 		$75K Hold
2,375
– – ﹤0.01% 215
2022
Q2 		$55K Hold
2,375
– – ﹤0.01% 227
2022
Q1 		$85K Hold
2,375
– – ﹤0.01% 227
2021
Q4 		$74K Hold
2,375
– – ﹤0.01% 247
2021
Q3 		$86K Hold
2,375
– – ﹤0.01% 234
2021
Q2 		$76K Hold
2,375
– – ﹤0.01% 253
2021
Q1 		$104K Hold
2,375
– – ﹤0.01% 240
2020
Q4 		$95K Buy
2,375
+1,125
+90% +$56.4K ﹤0.01% 252
2020
Q3 		$69K Buy
+1,250
New +$80.8K ﹤0.01% 249

Other funds holding BMRA

GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Potomac Capital Management New York $115M AUM
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $672M AUM 71.14% 1-Year Est. Return

Emerald Advisers's BMRA Position: Q1 2023 in Review

Emerald Advisers sold out of Biomerica (BMRA) in Q1 2023, closing a stake of 2,375 shares — an estimated $63.6K sold.

Emerald Advisers first reported a position in BMRA in Q3 2020 and held it in 10 quarters. The position peaked at $104K in Q1 2021. 34 funds tracked by Wall St. Rank hold BMRA as of Q1 2023.

  • Emerald Advisers reported no remaining Biomerica position as of Q1 2023 after selling out during the quarter.
  • Emerald Advisers sold 2,375 Biomerica shares in Q1 2023, an estimated $63.6K.
  • Emerald Advisers first reported a position in Biomerica in Q3 2020 and held it in 10 quarters.
  • Emerald Advisers's Biomerica position peaked at $104K in Q1 2021.
  • 34 funds tracked by Wall St. Rank held Biomerica as of Q1 2023.

Based on Emerald Advisers's 13F filing for Q1 2023, filed 4 May 2023.